OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
Cardiovascular disease (CVD) is the leading cause of death in North America and Europe. The
major cause of CVD is atherosclerosis like coronary artery disease (CAD). The results of
recent trials hint that the course of CAD may be positively influenced by an increased intake
of omega 3-fatty acids. The OMEGA-Trial analyses this effect in subjects who suffered an
acute myocardial infarction. They are divided into two groups, both receiving standard
post-infarction therapy. The subjects of one group additionally receive 1 gram of omega
3-fatty acids daily for a time-period of 12 months, while the subjects in the second group
receive 1 gram olive-oil as placebo. Within the period of 12 months all events are reported
and used to analyse the efficacy and safety of the additional therapy with omega 3-fatty
acids.